If the response to vitamin D supplementation could be modified by VDR SNPs, determining the distribution of VDR polymorphisms in both breast cancer survivors and healthy populations will provide a new, much-needed insight on individual’s vitamin D requirements to prevent cancer and its related mortality based on the genotypes of these individuals. The gene discussed is VDR; the disease is cancer.